(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BL BIOLYTICAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

BL BIOLYTICAL

ST13

US500000078596264

Class

5

Filing

78596264

Registration

3440596

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

60

Latest update

05/06/2022

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

03/28/2005

Registration date

06/03/2008

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/10/2018

Last transaction

05/06/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

03

Owner location

Richmond, British Columbia, CA

Examiner

BELLO, ZACK

Law office

M20

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of in part, a stylized representation of the letter "b" and the letter "L" combined within a circle.

Holders and representatives

Holders

BioLytical Laboratories Inc.

Representatives

Catherine Parrish Lake Dorsey & Whitney LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

In vitro diagnostic test kits comprising of reagents and instructions for detection of the presence of antibodies against Human Immunodeficiency Viruses (HIV)

Publications

History of USPTO decisions and trademark events.

60 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/06/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/06/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/18/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/18/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/18/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/18/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/18/2021

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/10/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/10/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/10/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/10/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

05/31/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/03/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/24/2017

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/24/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/21/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/21/2015

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED

08/08/2013

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

08/08/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/08/2013

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

07/22/2013

MAIL

PAPER RECEIVED

07/22/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

06/03/2008

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

04/28/2008

IUCN

NOTICE OF ALLOWANCE CANCELLED

04/23/2008

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

04/23/2008

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

11/20/2007

PUBO

PUBLISHED FOR OPPOSITION

08/28/2007

NPUB

NOTICE OF PUBLICATION

08/08/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/24/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/24/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

07/23/2007

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/19/2007

GNEA

EXAMINERS AMENDMENT E-MAILED

07/19/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/19/2007

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/10/2007

GNRT

NON-FINAL ACTION E-MAILED

07/10/2007

CNRT

NON-FINAL ACTION WRITTEN

07/10/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

07/03/2007

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/29/2007

GNEA

EXAMINERS AMENDMENT E-MAILED

06/29/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/29/2007

GNRT

NON-FINAL ACTION E-MAILED

01/17/2007

CNRT

NON-FINAL ACTION WRITTEN

01/17/2007

ACEC

AMENDMENT FROM APPLICANT ENTERED

01/17/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/17/2007

ALIE

ASSIGNED TO LIE

01/17/2007

MAIL

PAPER RECEIVED

12/15/2006

GNSI

INQUIRY TO SUSPENSION E-MAILED

12/02/2006

CNSI

SUSPENSION INQUIRY WRITTEN

12/02/2006

GNSL

LETTER OF SUSPENSION E-MAILED

05/31/2006

CNSL

SUSPENSION LETTER WRITTEN

05/31/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

05/31/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2006

MAIL

PAPER RECEIVED

04/27/2006

GNRT

NON-FINAL ACTION E-MAILED

10/24/2005

CNRT

NON-FINAL ACTION WRITTEN

10/24/2005

DOCK

ASSIGNED TO EXAMINER

10/22/2005

NWAP

NEW APPLICATION ENTERED

04/01/2005

Continuous trademark protection

Get notified about every new filing that threatens BL BIOLYTICAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.